Stay updated on BMS-986226 Immunotherapy Combo Clinical Trial
Sign up to get notified when there's something new on the BMS-986226 Immunotherapy Combo Clinical Trial page.

Latest updates to the BMS-986226 Immunotherapy Combo Clinical Trial page
- Check6 days agoChange DetectedLocations were updated to add multiple US and Canadian sites (Massachusetts, Missouri, New Jersey, Pennsylvania, Tennessee, Alberta, Ontario). The page revision was updated to v3.3.3 and the prior location blocks were removed.SummaryDifference0.7%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page now displays Revision: v3.3.2, replacing Revision: v3.3.1. This is a minor UI/version update and does not alter study content.SummaryDifference0.0%

- Check34 days agoChange DetectedThe page shows an update to the study document revision label (Revision: v3.3.1 added) and removal of v3.2.0, with no changes to core study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check42 days agoChange DetectedThe page removes a government funding status notice that warned information may be out of date and operations could be affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check56 days agoChange DetectedNo additions or deletions detected; the page content remains consistent with prior version aside from administrative updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check85 days agoChange DetectedUpgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.SummaryDifference2%

Stay in the know with updates to BMS-986226 Immunotherapy Combo Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BMS-986226 Immunotherapy Combo Clinical Trial page.